Table IV.

Comparison of prognosis among demographic and delivery variables.

		Normal Cases (%)	Adverse Outcomes Cases (%)	p-value
Gender	Male	10 (58.8)	7 (41.2)	0.453
	Female	8 (72.7)	3 (9.1)
Delivery method	Vaginal	11 (84.6)	2 (15.4)	*0.037
	Caesarean	7 (46.7)	8 (53.3)
Gravidity	Primigravida	11 (73.3)	4 (26.7)	0.283
	Multigravida	7 (53.8)	6 (46.2)
Parity	Primipara	14 (70.0)	6 (30.0)	0.318
	Multipara	4 (50.0)	4 (50.0)
Apgar score at 5 min	10	16 (69.6)	7 (30.4)	0.211
	9 or less	2 (40.0)	3 (60.0)

All variables were compared between cases with a normal prognosis (N = 18) and cases with adverse outcomes (N = 10) and excluded loss to follow-up cases (N = 5). Adverse outcomes included motor dysfunction, speech or motor delay, limb weakness or inflexibility, appendage adduction, and death. Comparisons were made using a chi-square test, with p < 0.05

^*considered statistically significant.